Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Hydroxide-Iodoform Paste vs Modified Triple Antibiotic Paste for Necrotic Primary Molars
NCT07773805Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jan 2027
- Primary completion
- Jan 2028
01
Overview
Randomised trial of calcium hydroxide + iodoform in dental pulp necrosis, apical periodontitis (AP) and dental caries (2 arms), sponsored by Cairo University. Primary endpoints: Pathological Mobility at 12 months, Soft Tissue Pathologies at 12 months and 2 more. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
calcium hydroxide + iodoform
03
Conditions
dental pulp necrosisapical periodontitis (AP)dental caries
Beyond the preview
Go deeper on NCT07773805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07773805.